PSMA-1007

CAT: 0804-HY-153550-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-153550-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
PSMA-1007 is a prostate-specific membrane antigen (PSMA) ligand. 18F-labeled PSMA-1007 can be used as a PET tracer for prostate cancer imaging. PSMA-1007 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) [1].
CAS Number
[2226894-58-0]
UNSPSC
12352209
Target
PSMA; Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/psma-1007.html
Purity
99.35
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC(CC[C@H](NC([C@@H](NC(C1=CC=C([N+](C)(C)C)N=C1)=O)CCC(O)=O)=O)C(NCC2=CC=C(C(N[C@@H](CC3=CC=C(C=CC=C4)C4=C3)C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)C=C2)=O)=O.[O-]C(C(F)(F)F)=O
Molecular Formula
C54H64F3N9O18
Molecular Weight
1184.13
References & Citations
[1]Mamlins E, et al. PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility. Mol Imaging Biol. 2023 Jun;25 (3) :554-559. |[2]Kim SB, et al. Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model. Mol Pharm. 2023 Feb 6;20 (2) :1050-1060.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 3

Popular Products